Biofil Chemicals & Pharmaceuticals29.37
+0.00 (-2.94%)

Biofil Chemicals & Pharmaceuticals Share Price

29.37+0.00 (-2.94%)
-22.83% past 1 Year

Corporate filings & documents

Announcements

Submission of publication of Un-audited financial results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
6 days ago
To review consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with limited review report
1 week ago
To review consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with Limited Review Report.
1 week ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Unaudited Financial Results of The Company for The Quarter and Half Year Ended on 30th September 2026 along with Limited Review Report thereon.
2 weeks ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Unaudited Financial Results of The Company for The Quarter and Half Year Ended on 30th September 2026 along with Limited Review Report thereon.
2 weeks ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th September 2026
1 month ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th September 2026
1 month ago
Intimation of closure of Trading window with effect from Thursday 01st October 2026
1 month ago
Intimation of closure of Trading window with effect from Thursday 01st October 2026
1 month ago
Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company upon attaining the age of 75 (seventy-five) years.
1 month ago
Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company upon attaining the age of 75 (seventy-five) years.
1 month ago
Scruitinizer report with voting results
1 month ago
Scruitinizer report with voting results
1 month ago
Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months ago
Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months ago
Pursuant to Regulation 30 44 and 47 of SEBI(LODR) Regulations 2015 and in compliance with Section 108 of the Companies Act 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper published on 28th August 2026 in Free Press Mumbai (English) Free Press Indore (English) and Choutha Sansar (Hindi) edition.
2 months ago
Pursuant to Regulation 30 44 and 47 of SEBI(LODR) Regulations 2015 and in compliance with Section 108 of the Companies Act 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper published on 28th August 2026 in Free Press Mumbai (English) Free Press Indore (English) and Choutha Sansar (Hindi) edition.
2 months ago
Information under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and Section 108 of the Companies Act 2013 regarding voting through electronic mode for the 41st Annual General Meeting scheduled to be held on Wednesday 23rd September 2026
2 months ago
Information under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and Section 108 of the Companies Act 2013 regarding voting through electronic mode for the 41st Annual General Meeting scheduled to be held on Wednesday 23rd September 2026
2 months ago
Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants
2 months ago
Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants
2 months ago
Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months ago
Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months ago
Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)
2 months ago
Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)
2 months ago
Newspaper publication of Notice of 41st AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM)
3 months ago
Newspaper publication of Notice of 41st AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM)
3 months ago
Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
3 months ago
Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
3 months ago
Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company notwithstanding his attaining the age of 75 (Seventy Five )Years
3 months ago
Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company notwithstanding his attaining the age of 75 (Seventy Five )Years
3 months ago
Un-Audited Financial Results for the quarter ended 30th June 2026
3 months ago
Un-Audited Financial Results for the quarter ended 30th June 2026
3 months ago
Outcome of Board Meeting held on Tuesday 11th August 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Outcome of Board Meeting held on Tuesday 11th August 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.
3 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.
3 months ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th June 2026.
4 months ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th June 2026.
4 months ago
Closure of Trading Window for the quarter ended 30.06.2026
5 months ago
Closure of Trading Window for the quarter ended 30.06.2026
5 months ago
Submission of publication of Audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
5 months ago
Submission of publication of Audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
5 months ago
Audited Financial Result for the Financial Year ended 31.03.2026
5 months ago
Outcome of Board Meeting held on Saturday 30th May 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
5 months ago
Outcome of Board Meeting held on Saturday 30th May 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
5 months ago
Submission of Annual Secretarial Compliance Report for the Financial year ended 31st March 2026
6 months ago
Submission of Annual Secretarial Compliance Report for the Financial year ended 31st March 2026
6 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026.
6 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026.
6 months ago

Concalls & investor presentations

Empty box

No presentations found

Biofil Chemicals & Pharmaceuticals Ltd Share Price Today

The Biofil Chemicals & Pharmaceuticals Ltd share price today is ₹29.38. During the trading session, the Biofil Chemicals & Pharmaceuticals Ltd share price opened at ₹30.4 and recorded an intraday high of ₹30.73 and a low of ₹29.01. Last closing price was ₹30.38. Over the past 52 weeks, the Biofil Chemicals & Pharmaceuticals Ltd share price has ranged between ₹25.6 and ₹46.34. The current Biofil Chemicals & Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.